BPA Call HT001424A0002-HT009025FG0310056
Award Date
3/20/25
Potential Completion Date
9/30/25
Potential Value
$29K
Federal Agency
Defense Health Agency
Awardee
Sofie CO.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q517 - Pharmacy Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as IBA Molecular, to provide radiopharmaceuticals needed for the treatment of prostate cancer patients with metastatic lesions. The contract has a ceiling value of $21,652.32 and is effective through September 30, 2025. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a for-profit organization specializing in the development, production, and delivery of molecular diagnostics and...
This federal contract award is for the delivery of FLUORODEOXYGLUCOSE FDG 1-15MCI and SODIUM FLUORIDE (F-18 NAF) radiopharmaceuticals to the Defense Health Agency (DHA), a defense agency. The $22,440 firm-fixed-price contract was awarded to Sofie CO., doing business as IBA Molecular, a for-profit organization that specializes in the development, production, and delivery of molecular diagnostics and therapeutics, particularly radiopharmaceuticals and positron emission tomography (PET) imaging...
This federal contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals required for patient care. The $10,826.16 Firm Fixed Price contract, awarded by the Defense Health Agency (DHA), is a Blanket Purchase Agreement (BPA) call that runs through September 30, 2024. Sofie is an established provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to various federal agencies, including the Department of Veterans...
This federal contract award, valued at $25,261.04, was granted to Sofie CO. (doing business as Sofie) by the Defense Health Agency (DHA) to provide radiopharmaceuticals needed for prostate cancer patients with metastatic lesions. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type and an ultimate completion date of September 30, 2025. Sofie is a subsidiary of Sofie Biosciences, Inc., specializing in the development and delivery of molecular diagnostics...
This federal contract award to Sofie CO., a subsidiary of Sofie Biosciences, Inc., is for the provision of radiopharmaceuticals to the Defense Health Agency (DHA) and supports medical imaging and cancer treatment programs for the Department of Defense. The $100,000.00 firm-fixed-price contract, which is not set-aside, covers the delivery of various radiopharmaceuticals, including positron emission tomography (PET) imaging agents, prostate cancer detection tools, and injectable cancer drugs....
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The $10,826.16 contract is for the supply of a radiopharmaceutical needed for prostate cancer patients with metastatic lesions after definitive treatment. The contract has an ultimate completion date of September 30, 2024. Sofie is a specialized provider of radiopharmaceuticals, pharmaceuticals, and...
This is a firm fixed-price BPA call order awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, in the amount of $249,249.48. The contract is for the delivery of the LIFE MOLECULAR IMAGING PRODUCT, which includes radiopharmaceuticals, pharmaceuticals, and related services to support medical imaging and cancer treatment programs for the Department of Veterans Affairs (VA) and military treatment facilities. Sofie is an experienced provider of specialized imaging agents,...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PET radiopharmaceuticals, which are specialized imaging agents used for medical diagnostics and cancer treatment. The award, valued at $188,258.00, is a delivery order under a larger $5.86 million Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network (VISN) 15 for the...
This federal contract award is for the delivery of radiopharmaceuticals and related services to the Department of Veterans Affairs (VA). The prime contractor, Sofie CO., is a subsidiary of Sofie Biosciences, Inc., a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a focus on radiopharmaceuticals. The contract has a ceiling value of $90,125.00 and is a firm-fixed-price delivery order, with an ultimate completion date of September 30, 2020. The contract is...
This federal contract award is for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, with a ceiling value of $751,599.72, was awarded to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract does not have a set-aside designation. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a focus on radiopharmaceuticals and positron emission tomography (PET) imaging agents. The company has...